Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 3
This trial compared obinutuzumab with rituximab for a type of low grade non Hodgkin lymphoma (NHL) called follicular lymphoma.
Recruitment start: 6 July 2011
Recruitment end: 4 February 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Robert Marcus
Experimental Cancer Medicine Centre (ECMC)
Genentech Ltd
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 29 January 2018
CRUK internal database number: 8402
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
